{"id":"https://openalex.org/W2018035901","doi":"https://doi.org/10.1097/00045391-200103000-00003","title":"Cyclooxygenase-2???Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients","display_name":"Cyclooxygenase-2???Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W2018035901","doi":"https://doi.org/10.1097/00045391-200103000-00003","mag":"2018035901","pmid":"https://pubmed.ncbi.nlm.nih.gov/11304662"},"language":"en","primary_location":{"id":"doi:10.1097/00045391-200103000-00003","doi":"https://doi.org/10.1097/00045391-200103000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00045391-200103000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S67118044","display_name":"American Journal of Therapeutics","issn_l":"1075-2765","issn":["1075-2765","1536-3686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109083618","display_name":"Andrew Whelton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Whelton","raw_affiliation_strings":["Universal Clinical Research Center, Inc., Baltimore, MD, USA","Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universal Clinical Research Center, Inc., Baltimore, MD, USA","institution_ids":[]},{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112473474","display_name":"John G. Fort","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John G. Fort","raw_affiliation_strings":["Pharmacia, 100 Route 206 North, Peapack, NJ 07977, USA; e-mail","Pharmacia, Peapack, NJ;","Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia, 100 Route 206 North, Peapack, NJ 07977, USA; e-mail","institution_ids":[]},{"raw_affiliation_string":"Pharmacia, Peapack, NJ;","institution_ids":[]},{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048586863","display_name":"Joseph A. Puma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A. Puma","raw_affiliation_strings":["The Heart and Vascular Center, Duke University Medical Center, Galax, VA;","Duke University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Heart and Vascular Center, Duke University Medical Center, Galax, VA;","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke University","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021855226","display_name":"Diane E. Normandin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210126654","display_name":"Clinical Research of West Florida","ror":"https://ror.org/03gg5y009","country_code":"US","type":"other","lineage":["https://openalex.org/I4210126654"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diane Normandin","raw_affiliation_strings":["Clinical Research of West Florida, Clearwater, FL;","Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research of West Florida, Clearwater, FL;","institution_ids":["https://openalex.org/I4210126654"]},{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109437428","display_name":"Alfonso E. Bello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alfonso E. Bello","raw_affiliation_strings":["Pharmacia, Peapack, NJ;","Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia, Peapack, NJ;","institution_ids":[]},{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084258579","display_name":"Kenneth M. Verburg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth M. Verburg","raw_affiliation_strings":["","Members listed in the Appendix","Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"Members listed in the Appendix","institution_ids":[]},{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5112473474"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":null,"apc_paid":null,"fwci":29.5767,"has_fulltext":false,"cited_by_count":330,"citation_normalized_percentile":{"value":0.99845027,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"8","issue":"2","first_page":"85","last_page":"95"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":1.0},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5870000123977661},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":0.9520000219345093},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.8240000009536743},{"id":"https://openalex.org/keywords/antihypertensive-drug-interactions","display_name":"antihypertensive drug interactions","score":0.7799999713897705},{"id":"https://openalex.org/keywords/edema","display_name":"edema","score":0.7760000228881836},{"id":"https://openalex.org/keywords/blood-pressure-control","display_name":"blood pressure control","score":0.6830000281333923},{"id":"https://openalex.org/keywords/nsaid-adverse-effects","display_name":"NSAID adverse effects","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9939885139465332},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.963270902633667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.956913948059082},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.7469427585601807},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.600691020488739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49432897567749023},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4580705165863037},{"id":"https://openalex.org/C2776164576","wikidata":"https://www.wikidata.org/wiki/Q62736","display_name":"Osteoarthritis","level":3,"score":0.43590080738067627},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3315780758857727},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05793944001197815},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002319","descriptor_name":"Cardiovascular System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011453","descriptor_name":"Prostaglandins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00045391-200103000-00003","doi":"https://doi.org/10.1097/00045391-200103000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00045391-200103000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S67118044","display_name":"American Journal of Therapeutics","issn_l":"1075-2765","issn":["1075-2765","1536-3686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Therapeutics","raw_type":"journal-article"},{"id":"pmid:11304662","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11304662","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310017","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1922681024","https://openalex.org/W1978759500","https://openalex.org/W1983370454","https://openalex.org/W2006508266","https://openalex.org/W2011487877","https://openalex.org/W2023243818","https://openalex.org/W2044750065","https://openalex.org/W2060514620","https://openalex.org/W2062335942","https://openalex.org/W2077018765","https://openalex.org/W2099995466","https://openalex.org/W2100822604","https://openalex.org/W2107864895","https://openalex.org/W2114634962","https://openalex.org/W2139480984","https://openalex.org/W2145343804","https://openalex.org/W2146625461","https://openalex.org/W2147254207","https://openalex.org/W2148371184","https://openalex.org/W2160950772","https://openalex.org/W2163756514","https://openalex.org/W2240587738","https://openalex.org/W2330496155","https://openalex.org/W2414167269","https://openalex.org/W2539339582","https://openalex.org/W3080346889","https://openalex.org/W4235435263","https://openalex.org/W4238900290"],"related_works":["https://openalex.org/W2015431243","https://openalex.org/W2028557369","https://openalex.org/W2065689558","https://openalex.org/W2076613880","https://openalex.org/W2004055683","https://openalex.org/W2037650808","https://openalex.org/W3121626603","https://openalex.org/W2144438239","https://openalex.org/W2108840350","https://openalex.org/W1993202690"],"abstract_inverted_index":{"BACKGROUND:":[0],"Arthritis":[1],"and":[2,30,59,83,111,130,134,243,262],"hypertension":[3],"are":[4],"common":[5],"comorbid":[6],"conditions":[7],"affecting":[8],"elderly":[9],"adults.":[10],"Use":[11],"of":[12,26,53,81,104,137,179,184,201,206,253,265],"nonsteroidal":[13],"anti-inflammatory":[14],"drugs":[15],"in":[16,71,107,113,123,177,199,219],"patients":[17,72,143,163,186,208],"treated":[18],"with":[19,39,73,161,182,204,230,270],"antihypertensive":[20,86,241],"medication":[21,146],"can":[22],"lead":[23],"to":[24],"destabilization":[25,264],"blood":[27,109,115,173,196,222,266],"pressure":[28,116,174,197,223,267],"control":[29,268],"other":[31],"cardiorenal":[32,51,254],"events.":[33,255],"The":[34,47,98],"potential":[35],"for":[36,227,233,250],"similar":[37],"interactions":[38],"cyclooxygenase-2-specific":[40,56,245],"inhibitors":[41,246],"has":[42],"not":[43],"been":[44],"fully":[45],"explored.":[46],"authors":[48],"evaluated":[49],"the":[50,102,124,215,251],"safety":[52],"two":[54],"new":[55],"inhibitors,":[57],"celecoxib":[58,91,234,258],"rofecoxib.":[60,273],"METHODS:":[61],"This":[62],"study":[63,145,192],"was":[64,224],"a":[65],"6-week,":[66],"randomized,":[67],"parallel-group,":[68],"double-blind":[69],"trial":[70],"osteoarthritis":[74],"who":[75],"were":[76,84,101],">":[77],"or":[78,94],"=65":[79],"years":[80],"age":[82],"taking":[85,240],"agents.":[87],"Patients":[88,239,256],"received":[89,144],"once-daily":[90],"200":[92],"mg":[93],"rofecoxib":[95,228],"25":[96],"mg.":[97],"primary":[99],"endpoints":[100],"development":[103,252],"edema,":[105],"changes":[106,112],"systolic":[108,221],"pressure,":[110],"diastolic":[114],"as":[117,157],"measured":[118],"at":[119,128,190],"any":[120,191],"time":[121,193],"point":[122],"study.":[125],"Measurements":[126],"occurred":[127],"baseline":[129,218],"after":[131],"1,":[132],"2,":[133],"6":[135],"weeks":[136],"treatment.":[138],"FINDINGS:":[139],"Eight":[140],"hundred":[141],"ten":[142],"(celecoxib,":[147],"n":[148,152],"=":[149,153,170,188,210,236],"411;":[150],"rofecoxib,":[151],"399).":[154],"Nearly":[155],"twice":[156],"many":[158],"rofecoxib-":[159,180,202],"compared":[160,181,203,229,269],"celecoxib-treated":[162,185,207],"experienced":[164,259],"edema":[165,261],"(9.5%":[166],"vs.":[167],"4.9%,":[168],"P":[169],"0.014).":[171],"Systolic":[172],"increased":[175,198],"significantly":[176],"17%":[178],"11%":[183],"(P":[187,209,235],"0.032)":[189],"point.":[194],"Diastolic":[195],"2.3%":[200],"1.5%":[205],"0.44).":[211],"At":[212],"week":[213],"6,":[214],"change":[216],"from":[217],"mean":[220],"+2.6":[225],"mmHg":[226,232],"-0.5":[231],"0.007).":[237],"CONCLUSIONS:":[238],"therapy":[242],"receiving":[244,257,272],"should":[247],"be":[248],"monitored":[249],"less":[260,263],"those":[271]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}